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Abstract  
This study was undertaken to determine the incidence and risk factors related to the 
occurrence of urinary tract infections (UTI), post surgery, in women being treated for a 
gynaecologic cancer. A retrospective case analysis of 215 women was conducted using data 
collected via case review with domains covering known risk factors for the occurrence of 
urinary infections. Bacteriuria was defined as greater than 105 colony-forming units per 
millilitre. 30.7% of women had a UTI postoperatively. 75.7% infections were Escherichia coli. 
Having a catheter in situ for ≤3 days was found to be slightly significant in the formation of a 
UTI postoperatively, U=3878, p<.05. Having a catheter in situ for ≥7 days was found to be 
highly significant, (2(1) =6.602, p<0.01), OR= 2.44. A positive correlation was found 
between the duration of the catheter in situ and type of UTI (=.251, p<.01). Although urinary 
catheterisation is known to be related to hospital acquired infection, a shorter duration of 
catheterisation may reduce the risk of possible infection post surgery. Oncology teams need 
to be more aware of this risk, identify women more likely to be catheterised for longer and 
use preventative strategies for managing infection, such as silver nitrite lined catheters. 
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complications. 
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Body of text 
Introduction 
Hospital acquired infections (nosocomial infections or healthcare associated infections 
[HCAIs]) are defined as “infections acquired in hospital likely to complicate illness, cause 
anxiety and discomfort and can lead to death” (NINSS 2002) or infections acquired “as a 
result of health care interventions” (HPA 2009). The results of the Third Prevalence Study of 
healthcare infections in England conducted in 2006 showed that urinary tract infections 
(UTIs) were among the most common health care associated infections (Smyth et al, 2008). 
UTIs accounted for 19.7% of total healthcare associated infections second only to 
gastrointestinal infections. HCAIs also carry substantial cost implications for the health 
service in the additional bed days and costs of medication. It is estimated that HCAIs will 
cost the NHS £124 million per year and cost approximately £1327 per infection (Plowman et 
al, 1999). 
It is good practice that prevention of nosocomial infections should be a priority for health 
care professionals as infection increases the morbidity and mortality of patients. The 
occurrence of a UTI combined with increased age, severity of underlying disease, type of 
hospital service (medicine/general surgery) and duration of catheterisation have been found 
to be significantly correlated with increased morbidity and mortality in patients (Platt et al, 
1982, Saint, 2000). In a review of the literature, the risk factors for a UTI were found to be a 
past history of UTIs, history of diabetes mellitus, postmenopausal, history of urinary tract 
3 
 
abnormalities (such as a cystocele or rectocele), frequent sexual intercourse, use of a 
diaphragm with spermicide, renal problems, bladder problems and pregnancy (Hu et al, 
2004, Boyko et al, 2005, Car and Sheikh, 2003, Sheffield and Cunningham, 2005) 
Women being treated for gynaecological cancer often have these characteristics and a long 
period of catheterisation. Surgery is one of the main treatment options for women with 
gynaeoncological cancer and catheterisation is a seemingly unavoidable part of this process 
as it aids postoperative voiding dysfunction caused by “anaesthesia, analgesia and 
immobility” (Wald et al, 2008a). The objective of this study was to determine risk factors for 
women undergoing gynaecological cancer in relation to UTI occurrence. An understanding of 
the risk factors for UTI in this population can improve risk assessment and will improve 
practice and ultimately improve patient outcome. 
 
Methods 
This study was a retrospective review of 215 medical notes to determine the risk factors for 
the development of UTIs in the gynaecologic oncology patient group. We also sought to 
develop a risk assessment tool to enable the speedy identification of high risk individuals 
and implementation of improved practice to decrease the incidence of a UTI. 
The researcher obtained a list of the details of women who had undergone gynaecological 
surgery for cancer in the years 2004 to 2005 at a large regional cancer centre within the UK. 
(See Fig. 1 for patient selection). 147 patients were excluded from the retrospective medical 
notes review as their procedures did not involve intraoperative and /or postoperative 
catheterisation. 
 
Fig. 1 Selection of study subjects 
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Ethical approval for this study was sought from the University Ethics Committee. Document 
agreement to conduct this study was obtained from the head of the Gynaecology 
Department and the Clinical Audit and Effectiveness department of the Trust. The proposed 
retrospective medical record review was assessed against the ethical principles for research, 
clinical audit and service review projects outlined by the Trust. All ethical principles were 
met.  
The proforma used for the retrospective medical notes review was based on the risk factors 
and the most common UTIs identified in the literature review. The microbiological laboratory 
of the Trust defined a UTI as a midstream sample or a catheter specimen sample of urine 
having a bacterial count of >105 colony-forming units per millilitre (cfuml-1). This definition of 
bacteriuria may  underestimate the incidence of UTIs in this high risk population (Stamm et 
al, 1982, Hamilton-Miller, 1997, Hooton, 2001, Dwyer and O’Reilly, 2002)  in oncology 
centres lower values are used to report UTIs but surgery is often conducted in general 
settings.. From nursing and medical documentation, a patient’s urine sample was only sent if 
women showed signs or symptoms of an infection, for example, burning on micturation, 
pyrexia and/or abdominal pain. 
To ensure external validity, the proforma was submitted for review by medical staff and 
nursing staff in the differing departments of the Gynaecology directorate to determine if all 
possible factors for urinary tract infection were covered. The relationship between 
categorical variables and the significance of this relationship were analysed using cross 
tabulations against the incidence of urinary tract infection.   Pearson’s chi-squared test (2), 
Cramer’s V, Mann Whitney U (MWU), and bivariate correlations, for example, Kendall’s Tau 
() were undertaken, as appropriate, to determine the significance of the findings. Data was 
analysed using SPSS v15 (SPSS Inc 2006, Chicago, IL, US). 
5 
 
Results 
The mean age of the women in the sample was 62 years. The age range of the sample was 
20 years to 88 years. The ratio of premenopausal to postmenopausal clients was 1:5 (16.3% 
vs. 83.7%). Four types of cancer were found in the sample. 39.5% of the population (n=85) 
had endometrial cancer, 37.2% (n=80) had ovarian cancer, 12.1% (n=26) had vulval cancer 
and 11.2% (n=24) had cervical cancer (Table 1).  
 
Table 1: Overview of the population in terms of the risk factors denoted in the literature 
 
Rates and types of infection 
30.7% (n-66) of the women had a postoperative UTI. Of this 66, Candidia accounted for 3% 
(n=2) of infections, Coliform for 13.6% (n=9), Citrobacter freundii for 1.5% (n=1), 
Enterobacter spp. for 1.5% (n=1), Escherichia coli (E.coli) for 75.7% (n=50), Proteus for 3% 
(n=2), Pseudomonas aeruginosa for 9% (n=6) and Staphylococcus aureus for 3% (n=2). 
Some women developed more than 1 infection during their admission. Although more 
procedures were conducted in 2005 [54% (n=116)], results show that there were marginally 
more infections for the year 2004 than for 2005 [54.5% (n=36) vs. 45.5% (n=30)]. 
The mean age of the population that developed a postoperative UTI was 63.4 years. 41% 
(n=27) had ovarian cancer, 36% (n=24) had endometrial cancer, 12% (n=8) had cervical 
cancer and 10% (n=7) had vulval cancer. 82% (n=54) were postmenopausal and 18% 
(n=12) were premenopausal. Of the 89.8% (n=193) of the sample that had antibiotics 
intraoperatively, 79% (n=169) had intravenous Coamoxiclav (ampicillin/amoxicillin) 1.2g. 
0.9% (n=2) of the women did not have prophylactic antibiotics intraoperatively as they were 
on antibiotics preoperatively. One patient was on long-term antibiotics. The second patient 
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had completed a course of antibiotics for a UTI immediately prior to surgery. There was no 
documentation of intraoperative antibioctics for 9.3% (n=20) of the sample.  
 
 
Contributory factors to the occurrence of urinary tract infections 
The key factors found to be a contributory factor for UTI were explored in the analysis: age, 
type of cancer being treated, menopausal status, history of diabetes, combined history of 
UTI, renal disease, uterine prolapse and urinary abnormalities, BMI and the presence of a 
UTI preoperatively. Despite these identified in the literature as possible risk factors, these 
were not found to be significant risk factors for the formation of a postoperative UTI in the 
women.  
There were a greater proportion of postmenopausal women to premenopausal women in the 
sample (n=180 vs. n=35). Subsequently, 82.8% of postoperative UTIs were found in the 
postmenopausal group. A statistical correlation between the type of uropathogen and 
menopausal status was deemed inappropriate due to small numbers in this subgroup. A 
small percentage of the women had a history of diabetes (13.1%) and only 3.8% of these 
women were diagnosed (positive urine culture) with a UTI postoperatively. Although data 
was combined for history of UTI, renal disease, uterine prolapse and urinary abnormalities, 
only 5.6% of the population had one or all of these co-morbidities. Only 2 women had a 
catheter in situ preoperatively and 1.9% of the population had a UTI preoperatively and 
postoperatively. 35.5% (n=60) of women who had Coamoxiclav (ampicillin/amoxicillin) 
intraoperatively went on to develop a postoperative UTI. 70% (n=42) of those infections were 
due to E. coli and 38.1% (n=16) of these infections were resistant to amoxicillin.  
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Unsurprisingly the duration of catheterisation was found to be the most significant factor in 
relation to UTI incidence. Having a catheter in situ for 7 days or more was found to be highly 
significant (2(1) =6.602, p<0.01), with an odds ratio of 2.44. The presence of a catheter for 
0-3days increased the risk of UTI formation as compared to 4-6 days (U=3878, p<.05, (mean 
ranks 112.97 vs. 93.09). Furthermore the duration of catheterisation was positively 
correlated with the type of uropathogen (=.251, p<.01). E. coli accounted for 21.5% of UTIs 
for days 0-3, 29.6% for days 4-6 and 31.6% for the ≥7 day group. 
Discussion 
Thirty-one percent (31%) of the sample population was found to have a postoperative UTI, 
suggesting that this is a common complication post therapy.  The Third Prevalence Survey 
for healthcare associated infections conducted in acute hospitals in 2006 found that 19.7% 
of the total healthcare associated infections were attributable to urinary tract infections 
(Smyth et al, 2008). A sub-analysis of the types of uropathogens encountered and the 
inclusion or exclusion of surgical oncology patients in this survey was not included.   
Past research studies have found that E. coli was the predominant uropathogen involved in 
catheter associated urinary tract infections (CAUTIs) (Wazait et al, 2003, Kucheria et al, 
2005). Their findings are quite similar to the findings of this study where E. coli accounted for 
75.7% of infections, Proteus accounted for 3%, Coliforms accounted for 13.6% and 
Pseudomonas aeruginosa accounted for 9% of infections (some clients had more than 1 
infection). Urethral epithelial cells can be normally colonised by Escherichia spp., Klebsiella 
spp., Proteus spp., Corynebacterium spp., Staphylococcus spp., and Candida spp. (Madigan 
et al, 2000). However, pathogenic infection can occur as a result of decreased immunity 
which may occur in cancer patients as a result of the disease or treatment. Perioperative 
stress has also been shown to result in immunosuppression and increased risk of 
postoperative infection (Hebert et al, 1999). This study may have under represented the 
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number of infections due to the higher threshold used by general hospitals in measuring 
infection. 
UTIs potentially cost health services approximately £19,500,000 per year (Plowman et al, 
1999, Smyth et al, 2008).Furthermore the psychological cost to the patient and their family is 
difficult to measure but could result in decreased mobility and delay in discharge. The 
synergistic effect of co-occurring symptoms may affect patient outcomes (Dodd et al, 2004), 
for example a reduction, delay or discontinuation of treatment.  This can add additional 
symptoms and discomfort at a time of anxiety for such women. 
The risk factors for postoperative UTI in the sample population were examined and found to 
be duration of catheterisation. The odds ratio predicted that an individual was 2.44 times 
more likely to develop a UTI postoperatively if they were catheterised for 7 days or more, 
which is supported by the literature (Shapiro et al. 1984).  
The literature search did not suggest that catheterisation up to 3 days was a factor in the 
formation of a UTI. However, a previous study (Wad et al, 2008a) found that patients 
catheterised for 2 days or more had double the likelihood of developing a UTI than those 
catheterised for 2 days or less. This study found that 23% of catheterisations from 0-3 days 
resulted in a postoperative UTI. This was significant at p<.05.  Approximately 80% of 
nosocomial UTIs are due to indwelling catheters (Plowman et al. 2001). Prior studies 
highlight that the risk of developing bacteriuria can increase by 5% for each day catheterised 
(Garibaldi et al, 1974, Schaeffer, 1986) and in one study (Garibaldi et al, 1974) 50% of 
patients developed bacteriuria after the tenth catheterised day. The data from this study 
supports the concept of accumulating risk of infection which is caused by catheterisation. 
Reducing the number of days that women are catheterised could have a substantive affect 
on reducing infection. 
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Reducing the use of urinary catheters is not easy in practice. Catheterisation is a 
fundamental part of gynaecological surgery as it aids postoperative bladder dysfunction 
(postoperative retention, frequency and hesitancy). Patient mobility can decrease due to 
prolonged catheterisation (Saint et al, 1999) but conversely patients remain catheterised due 
to this decreased mobility (Wald et al, 2008b). In light of the results of previous research and 
the findings of this study, removal of catheters at day 2 would be advantageous taking into 
account the patient’s “wellness” at the time of decision making.  
Risk assessing women prior to surgery and that with such surgical procedures catheter 
removal at day 2 is unlikely, the use of the silver alloy catheters may help in reducing the 
subsequent risk of urinary tract infection. Silver, being a non-toxic prominent broad spectrum 
antimicrobial has been shown to be effective against urinary infective agents, such as, 
Escherichia coli (Sondi and Salopek-Sondi, 2004, Davenport and Keeley, 2005). There is 
good evidence for the use of silver alloy catheters (Karchmer et al, 2000, Lai and 
Fontecchio, 2002) but are often not used at point of surgery because of higher costs. 
Healthcare professionals need to be able to identify those women at higher risk of prolonged 
catheterisation and take effective action to reduce risk. 
Another risk reducing measure is health education. This applies to all stakeholders, the 
patient, carers and healthcare professionals. National infection control guidelines emphasise 
the importance of personal hygiene, catheter care and patient and carer education (NICE, 
2003). Yet past (Bridger, 1997) and present (Wagg et al, 2005, Foxley, 2008) studies 
continue to show that nursing knowledge about catheter and catheter care was less than 
should be expected. Few women in this study had assessment of risk identified in their 
records. 
A UTI risk assessment tool as a result of this study has been formulated, taking into account 
the risk factors highlighted in and those identified in this study (Figure 2). Risk assessment is 
important in reducing infection and in planning future care.  
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We acknowledge that there are some limitations in reviewing cases from one NHS trust and 
that this was a relatively small sample for a risk analysis. This was a retrospective study and 
therefore reliant on good documentation with an adhoc approach to detecting urinary tract 
infections. This study has confirmed that increased duration of catheterisation is a 
substantive risk factor contributing to the incidence of UTI, and confirms the findings of other 
studies. It has also highlighted the significance of the elevated risk caused by catheterisation 
for 7 days or more, to the gynaeoncologic patient group.  
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Table 1: Overview of the population in terms of the risk factors denoted in the literature. 
 
FACTORS FREQUENCY(n) PERCENT (%) 
n=215  100% 
Age 
 
Mean 61.67years 
Range 20-88 
 
Body Mass Index (BMI):  
 
BMI<18.5 
BMI=18.5-25 
BMI=25-30 
BMI>30 
BMI Not recorded 
Median 28  
Range 15-63.5 
2 
56 
65 
77 
15 
 
 
0.9 
26 
30.2 
35.8 
7.1 
Cancer: 
Cervix 
Endometrium 
Ovary 
Vulva  
 
24 
85 
80 
26 
 
11.2 
39.5 
37.2 
12.1 
Menopausal status: 
Premenopausal 
Postmenopausal 
 
35 
180 
 
16.3 
83.7 
History of diabetes 29 13.5 
History of UTIs 14 6.5 
*History of co-morbidities 22 10.2 
History of uterine prolapse 16 7.4 
Catheter: 
Preoperatively 
Intraoperatively 
Postoperatively  
 
5 
213 
213 
 
2.3 
99.1 
99.1 
Catheter in situ>7days 39 18.3 
*History of co-morbidities include renal disease, bladder cancer, bowel cancer, breast 
cancer, ovarian cancer, cerebrovascular accident, urinary tract abnormalities. 
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Fig. 1: Selection of study subjects 
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Fig. 2: UTI risk assessment tool 
 
 
 
